Karolinska Development AB (publ)

Stockholm Stock Exchange KDEV.ST

Karolinska Development AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2023

Karolinska Development AB (publ) Net Cash Used For Investing Activities is NA for the year ending December 31, 2023. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Stockholm Stock Exchange: KDEV.ST

Karolinska Development AB (publ)

CEO	Dr. Viktor Drvota M.D., Ph.D.
IPO Date	April 15, 2011
Location	Sweden
Headquarters	Tomtebodavägen 23 A
Employees	8
Sector	Finance
Industries Venture Capital Hedge Funds Investment Banking & Asset Management Private Equity

Description

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.

Key trends

Past 5 years